ConductScience.org, home

Paper3486045

Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology.

MacPherson GG and 1 other. Cancer Immunol Immunother, 1986. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology. Papers, record 3486045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3486045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2024-04-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1MacPherson GGG G
2North RJR J

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EndotoxinsMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Cardiac Output
Glycoproteins
Macrophage Activation
Mice
Mice, Inbred C57BL
Necrosis
Neutrophils
Phagocytes
T-Lymphocytes
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16196106Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6196106PubMed
2333124Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.J Natl Cancer Inst1977https://conductscience.org/library/papers/333124PubMed
313741297Embedding in epoxy resins for ultrathin sectioning in electron microscopy.Stain Technol1960https://conductscience.org/library/papers/13741297PubMed
41000787Tumor necrosis factor.Clin Bull1976https://conductscience.org/library/papers/1000787PubMed
56391656
The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression.
Cancer Immunol Immunother1984https://conductscience.org/library/papers/6391656PubMed
74713170Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.Br J Cancer1973https://conductscience.org/library/papers/4713170PubMed
813850016Mechanisms of the hemodynamic effects of endotoxin.Physiol Rev1960https://conductscience.org/library/papers/13850016PubMed
9309922The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity.J Exp Med1978https://conductscience.org/library/papers/309922PubMed
106563942Role of histamine in the antitumour activity of endotoxin.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6563942PubMed
116319531Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan.J Exp Med1984https://conductscience.org/library/papers/6319531PubMed
126177893Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells.J Natl Cancer Inst1982https://conductscience.org/library/papers/6177893PubMed
136444236T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.J Exp Med1980https://conductscience.org/library/papers/6444236PubMed
145547059The mediator of cellular immunity. 3. Lymphocyte traffic from the blood into the inflamed peritoneal cavity.J Exp Med1971https://conductscience.org/library/papers/5547059PubMed
16458374Regional blood flow and its relationship to lymphocyte and lymphoblast traffic during a primary immune reaction.J Exp Med1979https://conductscience.org/library/papers/458374PubMed
1825290972Is tumor necrosis factor a physiological mediator?Immunol Today1984https://conductscience.org/library/papers/25290972PubMed
196334549The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6334549PubMed
201103152An endotoxin-induced serum factor that causes necrosis of tumors.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1103152PubMed
211167565Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity.J Immunol1975https://conductscience.org/library/papers/1167565PubMed
226370831The role of the macrophage in cardiac allograft rejection in the rat.Immunol Rev1984https://conductscience.org/library/papers/6370831PubMed
236368247Role of mononuclear phagocyte function in endotoxin-induced tumor necrosis.Eur J Cancer Clin Oncol1984https://conductscience.org/library/papers/6368247PubMed

See all 26 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
38673758Spin Trapping of Nitric Oxide by Hemoglobin and Ferrous Diethyldithiocarbamate in Model Tumors Differing in Vascularization.Int J Mol Sci2024https://conductscience.org/library/papers/38673758PubMed
36971591Translatable Drug-Loaded Iron Oxide Nanophore Sensitizes Murine Melanoma Tumors to Monoclonal Antibody Immunotherapy.ACS Nano2023https://conductscience.org/library/papers/36971591PubMed
8980389Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.Br J Cancer1996https://conductscience.org/library/papers/8980389PubMed
8579110Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors.Am J Pathol1996https://conductscience.org/library/papers/8579110PubMed
7686211Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.J Exp Med1993https://conductscience.org/library/papers/7686211PubMed
3115109Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.Am J Pathol1987https://conductscience.org/library/papers/3115109PubMed
2292139Vascular attack as a therapeutic strategy for cancer.Cancer Metastasis Rev1990https://conductscience.org/library/papers/2292139PubMed
1744160Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude mice.J Cancer Res Clin Oncol1991https://conductscience.org/library/papers/1744160PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3486045

GET https://conductscience.org/api/papers/v1/3486045/references?page=2